In the UK the National Institute for Health and Care Excellence (NICE) has just released a major study into and around new diagnosis and treatment guidelines for OA. It’s the headline article in today’s ToL, and although we don’t get a mention it makes for interesting reading. Cost of OA to the UKs National Health Service is apparently around $20 billion per annum, and it will be nice to get a slice of that.
In the UK the National Institute for Health and Care Excellence...
-
- There are more pages in this discussion • 1,426 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
0.035(13.7%) |
Mkt cap ! $101.4M | |||
| Open | High | Low | Value | Volume |
| 25.5¢ | 29.0¢ | 25.0¢ | $162.3K | 595.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 49897 | 28.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.0¢ | 24504 | 1 |
View Market Depth
| Last trade - 16.10pm 01/07/2024 (20 minute delay) ? |
| PAR (ASX) Chart |